Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine

Autor: S. Y. Ma, Paul M. Carvey, Toan Q. Vu, Jack W. Lipton, Heather C. Robie, Zaodung Ling, E. Y. Chen, Chong Wai Tong
Rok vydání: 2000
Předmět:
Zdroj: Journal of Neural Transmission. 107:159-176
ISSN: 1435-1463
0300-9564
DOI: 10.1007/s007020050014
Popis: The D3 preferring dopamine agonist pramipexole has been shown to attenuate the cell loss induced by levodopa in vitro. Pramipexole was herein evaluated in the 6-hydroxydopamine lesion model to determine its in vivo effect. Rats were treated with pramipexole or saline before and after an intracerebroventricular 6-hydroxydopamine injection. In the preliminary study, 6-hydroxydopamine produced a 68% reduction in striatal dopamine and a 62% loss in tyrosine hydroxylase immunoreactive (THir) cell counts in the substantia nigra. Pramipexole treated animals exhibited a 29% and a 27% reduction in striatal dopamine and THir cell counts, respectively. THir cell counts and striatal dopamine were significantly correlated. In the stereological study, 6-hydroxydopamine reduced THir cell counts by 47% in saline treated animals and 26% in pramipexole treated animals. These data demonstrate that pramipexole attenuates the biochemical and THir cell changes normally produced by 6-hydroxydopamine consistent with its neuroprotective actions in vitro.
Databáze: OpenAIRE